Loading
Trial visits take hours and cost people wages. Paying a fair hourly rate for time spent beyond normal care would make trials possible for those who cannot afford unpaid days off.
Participants receive a wage-equivalent payment for research-only time (extra visits, procedures, questionnaires), set to a local living wage, disclosed in consent, and paid regardless of completion to avoid coercion to continue. Ethics guidance would treat payment for time as ethically required rather than suspect. Test whether it shifts who enrols.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trial modernisation roadmap: the randomised trial → platforms and adaptive designs → decentralised, pragmatic and always-on, Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Trials do not represent the people who get cancer, Trials enrol too few, too slowly.